1
|
Marzuillo P, Guarino S, Alfiero S, Annicchiarico Petruzzelli L, Arenella M, Baccelli F, Brugnara M, Corrado C, Delcaro G, Di Sessa A, Gallotta G, Lanari M, Lorenzi M, Malgieri G, Miraglia Del Giudice E, Pecoraro C, Pennesi M, Picassi S, Pierantoni L, Puccio G, Scozzola F, Taroni F, Tosolini C, Venditto L, Pasini A, La Scola C, Montini G. Acute kidney injury in children hospitalised for febrile urinary tract infection. Acta Paediatr 2024. [PMID: 38641985 DOI: 10.1111/apa.17247] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/05/2024] [Revised: 04/02/2024] [Accepted: 04/08/2024] [Indexed: 04/21/2024]
Abstract
AIM To determine (i) prevalence and the risk factors for acute kidney injury (AKI) in children hospitalised for febrile urinary tract infection (fUTI) and (ii) role of AKI as indicator of an underlying VUR. AKI, in fact, is favoured by a reduced nephron mass, often associated to VUR. METHODS This retrospective Italian multicentre study enrolled children aged 18 years or younger (median age = 0.5 years) discharged with a primary diagnosis of fUTI. AKI was defined using Kidney Disease/Improving Global Outcomes serum creatinine criteria. RESULTS Of 849 children hospitalised for fUTI (44.2% females, median age 0.5 years; IQR = 1.8), 124 (14.6%) developed AKI. AKI prevalence rose to 30% in the presence of underlying congenital anomalies of the kidney and urinary tract (CAKUT). The strongest AKI predictors were presence of CAKUT (OR = 7.5; 95%CI: 3.8-15.2; p = 9.4e-09) and neutrophils levels (OR = 1.13; 95%CI: 1.08-1.2; p = 6.8e-07). At multiple logistic regression analysis, AKI during fUTI episode was a significant indicator of VUR (OR = 3.4; 95%CI: 1.7-6.9; p = 0.001) despite correction for the diagnostic covariates usually used to assess the risk of VUR after the first fUTI episode. Moreover, AKI showed the best positive likelihood ratio, positive predictive value, negative predictive value and specificity for VUR. CONCLUSION AKI occurs in 14.6% of children hospitalised for fUTI and is a significant indicator of VUR.
Collapse
Affiliation(s)
- Pierluigi Marzuillo
- Department of Woman, Child and of General and Specialized Surgery, Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy
| | - Stefano Guarino
- Department of Woman, Child and of General and Specialized Surgery, Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy
| | - Salvatore Alfiero
- Department of Woman, Child and of General and Specialized Surgery, Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy
| | | | - Mattia Arenella
- Department of Woman, Child and of General and Specialized Surgery, Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy
| | - Francesco Baccelli
- Pediatric Nephrology and Dialysis, Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy
| | | | - Ciro Corrado
- Pediatric Nephrology, "G. Di Cristina" Hospital, Palermo, Italy
| | - Giulia Delcaro
- Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy
| | - Anna Di Sessa
- Department of Woman, Child and of General and Specialized Surgery, Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy
| | - Giulia Gallotta
- Pediatric Nephrology and Dialysis, Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy
| | - Marcello Lanari
- Pediatric Emergency Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy
| | - Maya Lorenzi
- Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Pediatric Clinic, University of Verona, Verona, Italy
| | - Gabriele Malgieri
- Pediatric Nephrology and Dialysis Unit, Santobono Children's Hospital, Naples, Italy
| | - Emanuele Miraglia Del Giudice
- Department of Woman, Child and of General and Specialized Surgery, Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy
| | - Carmine Pecoraro
- Pediatric Nephrology and Dialysis Unit, Santobono Children's Hospital, Naples, Italy
| | - Marco Pennesi
- Institute for Maternal and Child Health-IRCCS Burlo Garofolo, Trieste, Italy
| | - Sara Picassi
- Pediatria C, Ospedale Donna Bambino, Verona, Italy
| | - Luca Pierantoni
- Pediatric Emergency Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy
| | - Giuseppe Puccio
- Department of Woman, Child and of General and Specialized Surgery, Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy
| | | | - Francesca Taroni
- Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Di Milano, Milano, Italy
| | | | - Laura Venditto
- Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Pediatric Clinic, University of Verona, Verona, Italy
| | - Andrea Pasini
- Pediatric Nephrology and Dialysis, Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy
| | - Claudio La Scola
- Pediatric Nephrology and Dialysis, Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy
| | - Giovanni Montini
- Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Di Milano, Milano, Italy
- Giuliana and Bernardo Caprotti Chair of Pediatrics, Department of Clinical Sciences and Community Health, University of Milan, Milano, Italy
| |
Collapse
|
2
|
Rohner K, Marlais M, Ahn YH, Ali A, Alsharief A, Novak AB, Brambilla M, Cakici EK, Candan C, Canpolat N, Yu-Hin Chan E, Decramer S, Didsbury M, Durao F, Durkan AM, Düzova A, Forbes T, Gracchi V, Güngör T, Horinouchi T, Demir BK, Kobayashi Y, Koskela M, Kurt-Sukur ED, La Scola C, Langan D, Li X, Malgieri G, Mastrangelo A, Min J, Mizerska-Wasiak M, Moussaoui N, Noyan A, Nuutinen M, O'Gormon J, Okamoto T, Oni L, Oosterveld M, Pańczyk-Tomaszewska M, Parmaksiz G, Pasini A, Rianthavorn P, Roelofs J, Shen Y, Sinha R, Topaloglu R, Torres DD, Udagawa T, Wennerström M, Yap YC, Tullus K. Outcome of immunosuppression in children with IgA vasculitis-related nephritis. Nephrol Dial Transplant 2024:gfae009. [PMID: 38211969 DOI: 10.1093/ndt/gfae009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2024] Open
Abstract
BACKGROUND AND HYPOTHESIS IgA vasculitis with nephritis (IgAVN) is the most common vasculitis in children. Treatment recommendations are, due to a lack of evidence, based on expert opinion resulting in variation. The aim of this study was to describe clinical presentation, treatment and outcome of an extremely large cohort of children with biopsy proven IgAVN to identify prognostic risk factors and signals of treatment efficacy. METHODS Retrospective data were collected on 1148 children with biopsy proven IgAVN between 2005 and 2019 from 41 international paediatric nephrology centres across 25 countries and analyzed using multivariate analysis. The primary outcome was estimated glomerular filtration rate (eGFR) and persistent proteinuria at last follow up. RESULTS The median follow up was 3.7 years (IQR 2-6.2). At last follow up, 29% of patients had an eGFR < 90 ml/min/1.73m2, 36% had proteinuria and 3% had chronic kidney disease stage 4-5. Older age, lower eGFR at onset, hypertension and histological features of tubular atrophy and segmental sclerosis were predictors of poor outcome. There was no evidence to support any specific second line immunosuppressive regimen to be superior to others, even when further analysing subgroups of children with reduced kidney function, nephrotic syndrome or hypoalbuminemia at onset. Delayed start of immunosuppressive treatment was associated with a lower eGFR at last follow up. CONCLUSION In this large retrospective cohort, key features associated with disease outcome are highlighted. Importantly there was no evidence to support that any specific immunosuppressive treatments were superior to others. Further discovery science and well-conducted clinical trials are needed to define accurate treatment and improve outcomes of IgAVN.
Collapse
Affiliation(s)
- Katharina Rohner
- Department of Pediatric Nephrology, University Children's Hospital Zurich, Switzerland
| | - Matko Marlais
- Paediatric Nephrology Department, Great Ormond Street Hospital for Children, London, UK
- UCL Great Ormond Street Institute for Child Health, University College London, UK
| | - Yo Han Ahn
- Department of Pediatrics, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - Alaa Ali
- Great North Children's Hospital Newcastle, UK
| | - Abrar Alsharief
- Department of Pediatric Nephrology, The Queen Silvia Children´s Hospital, Sahlgrenska University Hospital, Göteborg, Sweden
| | - Anja Blejc Novak
- Pediatric Nephrology Department, Children's Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia
| | - Marta Brambilla
- Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Grande Ospedale Maggiore Policlinico, Milan, Italy
| | - Evrim Kargin Cakici
- Dr Sami Ulus Maternity and Child Health and Diseases Training and Research Hospital, Department of Pediatric Nephrology, Ankara, Türkiye
| | - Cengiz Candan
- Instanbul Medeniyet University, Department of Pediatric Nephrology, Istanbul, Türkiye
| | - Nur Canpolat
- Department of Pediatric Nephrology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Türkiye
| | - Eugene Yu-Hin Chan
- Paediatric Nephrology Centre, Hong Kong Children's Hospital, Hong Kong
- Department of Paediatric and Adolescent Medicine, Faculty of Medicine, The University of Hong Kong
| | - Stéphane Decramer
- Paediatric Nephrology Centre, Hôpital des Enfants, CHU Purpan, Centre de Référence du Sud-Ouest des Maladies Rénales Rares SORARE, Filière ORKiD Toulouse, France
| | - Madeleine Didsbury
- Department of Nephrology, Royal Children's Hospital, Melbourne, Australia
| | - Filipa Durao
- Pediatric Nephrology and Kidney Transplantation Unit, Department of Pediatrics, Hospital Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal
- Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
| | - Anne M Durkan
- Department of Nephrology, The Children's Hospital at Westmead, Sydney, Australia
| | - Ali Düzova
- Division of Pediatric Nephrology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Türkiye
| | - Thomas Forbes
- Department of Nephrology, Royal Children's Hospital, Melbourne, Australia
- Murdoch Children's Research Institute, Melbourne, Australia
| | - Valentina Gracchi
- Department of pediatric nephrology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Tulin Güngör
- Dr Sami Ulus Maternity and Child Health and Diseases Training and Research Hospital, Department of Pediatric Nephrology, Ankara, Türkiye
| | - Tomoko Horinouchi
- Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Belde Kasap Demir
- İzmir Katip Çelebi University, Department of Pediatrics, Division of Pediatric Nephrology and Rheumatology, Türkiye
- Health Sciences University Tepecik Training and Research Hospital, Divisions of Pediatric Nephrology and Rheumatology, Türkiye
| | - Yasuko Kobayashi
- Gunma University Graduate School of Medicine, Department of Pediatric, Gunma, Japan
| | - Mikael Koskela
- Department of Pediatric Nephrology and Transplantation, New Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
| | - Eda Didem Kurt-Sukur
- Division of Pediatric Nephrology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Türkiye
| | - Claudio La Scola
- Nephrology and Dialysis Unit, Department of Pediatrics. IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy
| | - Dean Langan
- UCL Great Ormond Street Institute for Child Health, University College London, UK
| | - Xiaozhong Li
- Pediatric Nephrologic and Immunologic Department, Children's hospital of Soochow University, China
| | - Gabriele Malgieri
- Division of Nephrology, Dialysis and Transplant, AORN Santobono Pausilipon, Napoli, Italy
| | - Antonio Mastrangelo
- Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Grande Ospedale Maggiore Policlinico, Milan, Italy
| | - Jeesu Min
- Department of Pediatrics, Chungnam National University Sejong Hospital, Sejong, Korea
| | | | - Nabila Moussaoui
- Paediatric Nephrology Centre, Hôpital des Enfants, CHU Purpan, Centre de Référence du Sud-Ouest des Maladies Rénales Rares SORARE, Filière ORKiD Toulouse, France
| | - Aytul Noyan
- Baskent University, Dr Turgut Noyan Training and Research Center, Department of Pediatric Nephrology, Adana, Türkiye
| | - Matti Nuutinen
- Department of Children and Adolescents, Oulu University Hospital, Oulu, Finland
- PEDEGO Research Unit, Research Unit for Pediatrics, Dermatology, Clinical Genetics, Obstetrics and Gynecology, Medical Research Center Oulu (MRC Oulu)
| | | | - Takayuki Okamoto
- Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan
| | - Louise Oni
- Department of Women's and Children's health, Alder Hey Children's NHS Foundation Trust Hospital and University of Liverpool, UK
| | - Michiel Oosterveld
- Emma Children's Hospital, Amsterdam University Medical Center, Amsterdam, Netherlands
| | | | - Gonul Parmaksiz
- Baskent University, Dr Turgut Noyan Training and Research Center, Department of Pediatric Nephrology, Adana, Türkiye
| | - Andrea Pasini
- Nephrology and Dialysis Unit, Department of Pediatrics. IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy
| | - Pornpimol Rianthavorn
- Department of Pediatrics, Faculty of Medecine, Chulalongkorn University, Bangkok, Thailand
| | - Joris Roelofs
- Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, Netherlands
| | - Yunyan Shen
- Pediatric Nephrologic and Immunologic Department, Children's hospital of Soochow University, China
| | - Rajiv Sinha
- Division of Pediatric Nephrology, Institute of Child Health, Kolkata, India
| | - Rezan Topaloglu
- Division of Pediatric Nephrology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Türkiye
| | | | - Tomohiro Udagawa
- Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan
| | - Martin Wennerström
- Department of Pediatric Nephrology, The Queen Silvia Children´s Hospital, Sahlgrenska University Hospital, Göteborg, Sweden
| | - Yok Chin Yap
- Department of Paediatric, Hospital Tunku Azizah, Women and Children Hospital Kuala Lumpur, Malaysia
| | - Kjell Tullus
- Paediatric Nephrology Department, Great Ormond Street Hospital for Children, London, UK
| |
Collapse
|
3
|
Annicchiarico Petruzzelli L, Minale B, Serio V, De Luca A, Marino Marsilia G, Campione S, Diomedi Camassei F, D'Arcangelo R, Luongo I, Lepore L, Giannattasio P, Molino D, Pirro L, Lonardo MC, Malgieri G, Pecoraro C. Pediatric Minimal Change Disease and AKI following the Pfizer-BioNTech COVID-19 Vaccine: causal or incidental correlation? G Ital Nefrol 2022; 39:39-06-2022-04. [PMID: 36655832] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
The global coronavirus 2019 (COVID-19) pandemic required vaccination even in children to reduce infection. We report on the development of acute kidney injury (AKI) and minimal change disease (MCD) nephrotic syndrome (NS), shortly after the first injection BNT162b2 COVID-19 vaccine (Pfizer-BioNTech). A 12-year-old previously healthy boy was referred to our hospital with complaints of peripheral edema and nephrotic range proteinuria. Nine days earlier he had received his first injection BNT162b2 COVID-19 vaccine (Pfizer-BioNTech). Seven days after injection, he developed leg edema, which rapidly progressed to anasarca with significant weight gain. On admission, serum creatinine was 1.3 mg/dL and 24-hour urinary protein excretion was 4 grams with fluid overload. As kidney function continued to decline over the next days, empirical steroid treatment and renal replacement therapy with ultrafiltration were started and kidney biopsy was performed. Seven days after steroid therapy, kidney function began to improve, gradually returning to normal. The association of MCD, nephrotic syndrome and AKI hasn't been previously described following the Pfizer-BioNTech COVID-19 vaccine in pediatric population, but this triad has been reported in adults. We need further similar case reports to establish the real incidence of this possible vaccine side effect.
Collapse
Affiliation(s)
| | - Bruno Minale
- Paediatric Nephrology, Dialysis and Renal Transplantation Santobono Pausilipon Children's Hospital, Naples, Italy
| | - Vittorio Serio
- Paediatric Nephrology, Dialysis and Renal Transplantation Santobono Pausilipon Children's Hospital, Naples, Italy
| | - Angela De Luca
- Paediatric Nephrology, Dialysis and Renal Transplantation Santobono Pausilipon Children's Hospital, Naples, Italy
| | | | - Severo Campione
- Section of Pathology, Antonio Cardarelli Hospital, Naples, Italy
| | | | - Rosamunda D'Arcangelo
- Paediatric Nephrology, Dialysis and Renal Transplantation Santobono Pausilipon Children's Hospital, Naples, Italy
| | - Ilaria Luongo
- Paediatric Nephrology, Dialysis and Renal Transplantation Santobono Pausilipon Children's Hospital, Naples, Italy
| | - Lorenza Lepore
- Emergency department, Antonio Cardarelli Hospital, Naples, Italy
| | - Paolo Giannattasio
- Paediatric Nephrology, Dialysis and Renal Transplantation Santobono Pausilipon Children's Hospital, Naples, Italy
| | - Daniela Molino
- Paediatric Nephrology, Dialysis and Renal Transplantation Santobono Pausilipon Children's Hospital, Naples, Italy
| | - Laura Pirro
- Paediatric Nephrology, Dialysis and Renal Transplantation Santobono Pausilipon Children's Hospital, Naples, Italy
| | - Maria Concetta Lonardo
- Paediatric Nephrology, Dialysis and Renal Transplantation Santobono Pausilipon Children's Hospital, Naples, Italy
| | - Gabriele Malgieri
- Paediatric Nephrology, Dialysis and Renal Transplantation Santobono Pausilipon Children's Hospital, Naples, Italy
| | - Carmine Pecoraro
- Paediatric Nephrology, Dialysis and Renal Transplantation Santobono Pausilipon Children's Hospital, Naples, Italy
| |
Collapse
|
4
|
della Valle M, D'Abrosca G, Gentile MT, Russo L, Isernia C, Di Gaetano S, Avolio R, Castaldo R, Cocca M, Gentile G, Malgieri G, Errico ME, Fattorusso R. Polystyrene nanoplastics affect the human ubiquitin structure and ubiquitination in cells: a high-resolution study. Chem Sci 2022; 13:13563-13573. [PMID: 36507175 PMCID: PMC9682910 DOI: 10.1039/d2sc04434j] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2022] [Accepted: 10/31/2022] [Indexed: 11/13/2022] Open
Abstract
Humans are estimated to consume several grams per week of nanoplastics (NPs) through exposure to a variety of contamination sources. Nonetheless, the effects of these polymeric particles on living systems are still mostly unknown. Here, by means of CD, NMR and TEM analyses, we describe at an atomic resolution the interaction of ubiquitin with polystyrene NPs (PS-NPs), showing how a hard protein corona is formed. Moreover, we report that in human HeLa cells exposure to PS-NPs leads to a sensible reduction of ubiquitination. Our study overall indicates that PS-NPs cause significant structural effects on ubiquitin, thereby influencing one of the key metabolic processes at the base of cell viability.
Collapse
Affiliation(s)
- M. della Valle
- Department of Environmental, Biological and Pharmaceutical Science and Technology, University of Campania – Luigi VanvitelliVia Vivaldi 4381100 CasertaItaly
| | - G. D'Abrosca
- Department of Environmental, Biological and Pharmaceutical Science and Technology, University of Campania – Luigi VanvitelliVia Vivaldi 4381100 CasertaItaly
| | - M. T. Gentile
- Department of Environmental, Biological and Pharmaceutical Science and Technology, University of Campania – Luigi VanvitelliVia Vivaldi 4381100 CasertaItaly
| | - L. Russo
- Department of Environmental, Biological and Pharmaceutical Science and Technology, University of Campania – Luigi VanvitelliVia Vivaldi 4381100 CasertaItaly
| | - C. Isernia
- Department of Environmental, Biological and Pharmaceutical Science and Technology, University of Campania – Luigi VanvitelliVia Vivaldi 4381100 CasertaItaly
| | - S. Di Gaetano
- Institute of Biostructures and Bioimaging-CNRVia Mezzocannone 1680134 NaplesItaly
| | - R. Avolio
- Institute for Polymers, Composites and Biomaterials – CNRVia Campi Flegrei, 34, 80078 PozzuoliNaplesItaly
| | - R. Castaldo
- Institute for Polymers, Composites and Biomaterials – CNRVia Campi Flegrei, 34, 80078 PozzuoliNaplesItaly
| | - M. Cocca
- Institute for Polymers, Composites and Biomaterials – CNRVia Campi Flegrei, 34, 80078 PozzuoliNaplesItaly
| | - G. Gentile
- Institute for Polymers, Composites and Biomaterials – CNRVia Campi Flegrei, 34, 80078 PozzuoliNaplesItaly
| | - G. Malgieri
- Department of Environmental, Biological and Pharmaceutical Science and Technology, University of Campania – Luigi VanvitelliVia Vivaldi 4381100 CasertaItaly
| | - M. E. Errico
- Institute for Polymers, Composites and Biomaterials – CNRVia Campi Flegrei, 34, 80078 PozzuoliNaplesItaly
| | - R. Fattorusso
- Department of Environmental, Biological and Pharmaceutical Science and Technology, University of Campania – Luigi VanvitelliVia Vivaldi 4381100 CasertaItaly
| |
Collapse
|
5
|
Pedoto D, Corcione A, Apuzzo D, Nuzzi F, Annicchiarico Petruzzelli L, Barra G, Malgieri G, Pecoraro C. P1814ATYPICAL FEATURES IN A TYPICAL DISEASE: ONE THOUSANDS FACES OF IGA NEPHROPATHY IN PAEDIATRIC PATIENTS. Nephrol Dial Transplant 2020. [DOI: 10.1093/ndt/gfaa142.p1814] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background and Aims
Immunoglobulin A Nephropathy (IgAN) is the most common cause of idiopathic glomerulonephritis in paediatric patients.
The typical presentation is characterized by recurrent episodes of macroscopic haematuria or persistent microhaematuria with mild or overt proteinuria. Renal function is normally preserved, though a slow progression to chronic kidney disease (CKD) may occur.
However, in rare cases IgAN may assume atypical features, presenting with nephrotic syndrome (NS), acute kidney injury (AKI) or assuming the characteristic of a rapidly progressive glomerulonephritis, leading to significant difficulties in management and critical impact on prognosis.
Method
Of total 756 renal biopsies performed in our centre from 2000 till 2019, 174 (23%) diagnosis of IgA nephropathy were made: 123 (70,6%) of 174 with a milder histological stage (I or II according to Lee’s) and 51 (29,3%) with severe stages (III-IV).
Clinical onset of these 51 patients was mostly characterized by a nephritic syndrome with micro-macrohaematuria, though in 7 of them it assumed atypical features (table 1).
Results
Patients 1, 2, 3 and 4 showed a rapidly progressive IgAN with extensive crescentic lesions at histological evaluation.
In all of the four patients the onset of the disease was characterised by a compromised renal function, thought, according to the medical history, in patients 2 and 4 clinical signs of nephropathy had started some months before the first medical evaluation.
This detail, considering the poorer clinical outcome of patients 2 and 4 (table 1), strongly highlights the need of promptness in the treatment of these conditions.
Patient 1 achieved a complete remission after steroid pulse therapy (Pozzi scheme), while for patients 2,3,4 an additional immunosuppressive treatment was required.
The nephropathy of patient 5 was, instead, characterized by AKI with consistent macrohaematuria. Interestingly, the severity of the clinical presentation was not related to the glomerular lesion (the histology showed a minimal change disease), rather to the intra-tubular haemorrhage, causing an obstructive acute kidney injury. Patient 5 achieved a complete remission after steroid treatment.
The onset of IgAN in patients 6 and 7 was characterized by a nephrotic syndrome, which is a very uncommon feature (<2% of all IgAN).
Patient 6, who showed a massive proteinuria (till 11 grams/24 hours) was promptly treated with steroid and tacrolimus, achieving a complete remission in 6 moths.
Patient 7, a sri-lankan girl, was diagnosed in 2008 in Sri-Lanka.
She underwent treatment with steroid and Mycophenolate and successively, for the persistence of proteinuria, with Cyclosporine A.
From 2014 she has been followed by our centre. Despite a second cycle with Cyclosporine she has shown a persistence of proteinuria and a slow progression to CKD.
Conclusion
This study highlights that a typical disease like IgAN may hide behind an atypical and severe presentation.
Moreover, the blackboard of the atypical forms is extremely heterogeneous, stretching from NS to crescentic and progressive diseases.
As a consequence, the treatment of these conditions is not codified and represents an important challenge for the clinician.
This calls for multicentric studies which could provide shared recommendation for the management of these atypical forms of IgAN.
Collapse
Affiliation(s)
- Deianira Pedoto
- Federico II University, Department of Medical Translational Sciences, Naples, Italy
| | - Adele Corcione
- Federico II University, Department of Medical Translational Sciences, Naples, Italy
| | - Diletta Apuzzo
- Federico II University, Department of Medical Translational Sciences, Naples, Italy
| | - Francesca Nuzzi
- Santobono-Pausilipon Children's Hospital, Paediatric Nephrology Unit, Naples, Italy
| | | | | | - Gabriele Malgieri
- Santobono-Pausilipon Children's Hospital, Paediatric Nephrology Unit, Naples, Italy
| | - Carmine Pecoraro
- Santobono-Pausilipon Children's Hospital, Paediatric Nephrology Unit, Naples, Italy
| |
Collapse
|
6
|
Apuzzo D, Annicchiarico Petruzzelli L, Ascione S, Corcione A, Pedoto D, Barra G, Rocco MC, Pecoraro C, Malgieri G. P0165HYPERTENSION IN OVERWEIGHT AND OBESE CHILDREN: IMPACT ASSESMENT OF ABPM PARAMETERS. Nephrol Dial Transplant 2020. [DOI: 10.1093/ndt/gfaa142.p0165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background and Aims
We describe the relationship between overweight and obesity and Hypertension on ABPM.
Method
We conducted a cross-sectional study using a database of patients aged 6-16 years, who had undergone 24h ABPM from December 2002 through December 2016. ABPM were performed using the validated device Spacelab 90217. Were evaluated the 24h MAP, daytime MAP, nocturnal MAP, systolic and diastolic load, MAP Systolic and Diastolic. Subjects were grouped by BMI Z-score into overweight (>1<2), obese (BMI Z-score >2<3) and severe obese (BMI Z-score >3). A total of 1016 patients were enrolled and recorded n.1210 ABPMs. Obese pts were 202 (19.8%); 126 M;76F;median age 10,2 y. Overweight childrens were 97 (11.9%);52 M;45F;median age 8,4y.
Results
Among overweight childrens (BMI Z-Score >1<2): 12 (12.3%) had hypertension, 22 (22.6%) pre-hypertension, 15 (15.4%) MH; non dipping pattern was recorded in 26 (52%). 48 were normotensive. Among obese childrens, 122 had hypertension (60.3%): 24 pts had Masked Hypertension (19.6%); 72 (59.0%) had severe ambulatory hypertension with BMI z-score >3 (mean 3.8) ,and in this category all pts were both systolic and diastolic non dipping. 32 (64%) obese with BMI z-score >2, <3 were non-dipping. Diastolic load was significantly higher (p>0,0001) in severe obese. 28 pts had ambulatory prehypertension (13.8%), 11 pts had White Coat Hypertension (4.9%).41 pts had normotension (20.2%).
Conclusion
The severity of ambulatory hypertension increased with increased BMI Z-score. The non-dipping status is associated, not only with higher BMI Z-score, but was present in overweight and obese with BMI z-score >2<3 also. ABPM is an effective tool that should become routine in all obese patient, but also in overweight childrens, which may lead to better treatments and prevention methods.
Collapse
Affiliation(s)
- Diletta Apuzzo
- Santobono Childrens Hospital, Pediatric Nephrology, Napoli, Italy
| | | | - Serena Ascione
- Santobono Childrens Hospital, Pediatric Nephrology, Napoli, Italy
| | - Adele Corcione
- Santobono Childrens Hospital, Pediatric Nephrology, Napoli, Italy
| | - Deianira Pedoto
- Santobono Childrens Hospital, Pediatric Nephrology, Napoli, Italy
| | - Giuseppina Barra
- Santobono Childrens Hospital, Pediatric Nephrology, Napoli, Italy
| | | | - Carmine Pecoraro
- Santobono Childrens Hospital, Pediatric Nephrology, Napoli, Italy
| | | |
Collapse
|
7
|
Annicchiarico Petruzzelli L, Serio V, Luongo I, Molino D, Minale B, Lepore L, Ascione S, Lubrano C, Malgieri G, Pecoraro C. P1369ACUTE EXTRACORPOREAL DIALYSIS USING TWO-WAY PICC POWER INJECTABLE IN YOUNG CHILDREN. Nephrol Dial Transplant 2020. [DOI: 10.1093/ndt/gfaa142.p1369] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background and Aims
Acute extracorporeal dialysis is a short treatment, performed by a central venous catheter of large size, ensuring high flow. These devices have limitations: high caliber, excessive length, impossibility of tunneling and exit-site location in the supraclavicular region, with a subsequent high risk of dislocation and contamination. The authors report a new approach to dialytic central venous catheters selection in children.
Method
From January 2013 to December 2017, 16 children weighing less than 15 kg needed acute extracorporeal dialysis. Patients received an ultrasound guided percutaneous implantation of a two-way PICC power injectable catheter, in the right internal jugular vein or in the anonymous right vein. The device size always respected the ratio of 1/3; the catheters were cut to be adapted to child height, and subclavear tunnelizations and stabilizations were ensured. The hemodialysis was performed with the Prismaflex Gambro system. The effectiveness of treatment was evaluated by recirculation test and by measuring the KT/Vat the third hour, expressing the dialysis adequacy.
Results
Two-way power injectable central venous catheter,sized from 5 to 7 Fr and long from 8 to 15 cm were used. The recorded blood flow ranged from 4.7ml/min/kg to 7ml/min/kg; a KT/V variable from 0.5 to 1 was detected; the recycling rate was between 32% and 40%. No catheter related complications were observed.
Conclusion
In children weighing less than 15 kg, PICC power injectable have lower blood flow and higher recirculation rate compared to traditional dialysis catheters. However, the dialytic adequacy was suitable for an acute hemodialysis treatment. In addition, these catheters are available in a wide range of calibers and result more adaptable to the venous system of younger children.
Collapse
Affiliation(s)
| | - Vittorio Serio
- A.O.R.N. Santobono-Pausilipon - Ospedale Santobono, Nephrology and Dialysis, Napoli, Italy
| | - Ilaria Luongo
- A.O.R.N. Santobono-Pausilipon - Ospedale Santobono, Nephrology and Dialysis, Napoli, Italy
| | - Daniela Molino
- A.O.R.N. Santobono-Pausilipon - Ospedale Santobono, Nephrology and Dialysis, Napoli, Italy
| | - Bruno Minale
- A.O.R.N. Santobono-Pausilipon - Ospedale Santobono, Nephrology and Dialysis, Napoli, Italy
| | - Lorenza Lepore
- A.O.R.N. Santobono-Pausilipon - Ospedale Santobono, Nephrology and Dialysis, Napoli, Italy
| | - Serena Ascione
- A.O.R.N. Santobono-Pausilipon - Ospedale Santobono, Nephrology and Dialysis, Napoli, Italy
| | - Carmen Lubrano
- A.O.R.N. Santobono-Pausilipon - Ospedale Santobono, Nephrology and Dialysis, Napoli, Italy
| | - Gabriele Malgieri
- A.O.R.N. Santobono-Pausilipon - Ospedale Santobono, Nephrology and Dialysis, Napoli, Italy
| | - Carmine Pecoraro
- A.O.R.N. Santobono-Pausilipon - Ospedale Santobono, Nephrology and Dialysis, Napoli, Italy
| |
Collapse
|
8
|
Corcione A, Apuzzo D, Pedoto D, Barra G, Annicchiarico Petruzzelli L, Pecoraro C, Malgieri G, Ascione S, Barra P, Pagano A, Lepore L. P1831ABPM DIFFERENCE BETWEEN OBESE AND NON OVERWEIGHT HYPERTENSIVE CHILDREN. Nephrol Dial Transplant 2020. [DOI: 10.1093/ndt/gfaa142.p1831] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background and Aims
The goal of our study was to analyze the difference in ABPM pattern in overweight and non overweight hypertensive children
Method
The ABPM were performed using Spacelab 90207 and recorded over 24h.Readings were taken every 15 minutes while awake,and every 20 minutes while asleep. In both groups were evaluated the 24h MAP,daytime MAP,nocturnal MAP, systolic and diastolic load,mean 24h SBP and DBP.
A total of 108 pts were enrolled. Pts were divided in two groups.In the first group 54 pts non overweight with primary hypertension:33 male and 21 female with mean age of 10.4 y. In the second group the obese hypertensive children, with mean age of 10.5 y, were divided into two subgroups according to BMI Z-scores:subgroup 1 BMI Z-score >2<3 n 40 pts (17 f;21m); subgroup 2 BMI Z-score >3 n (4f;10m).
Results
Systolic load was significantly higher in obese group (p 0,0409).In obese group n.12 were dipper (22,2%).Obese with BMI zscore >3 was all non dipper (n14 ;100%). In the lean group n 26 was dipper (48.1%),and 28 (51.8%) non dipper. 24 h MAP, Systolic and Diastolic load were significantly higher (p 0,0001) in the obese with BMI z score >3 compared to the lean group.
Conclusion
The statistically significant pathological pattern among obese is the increase inmean PAS and systolic load, as well as the absence of night dipping in severe obese. The increase in systolic load is already evident in obese mild.This gives a significant predictive value of cardiovascular damage to ABPM which increases with the severity of obesity worse.
Collapse
Affiliation(s)
- Adele Corcione
- A.O.R.N. Santobono-Pausilipon - Ospedale Santobono, Pediatric Nephrology, Napoli, Italy
| | - Diletta Apuzzo
- A.O.R.N. Santobono-Pausilipon - Ospedale Santobono, Pediatric Nephrology, Napoli, Italy
| | - Deianira Pedoto
- A.O.R.N. Santobono-Pausilipon - Ospedale Santobono, Pediatric Nephrology, Napoli, Italy
| | - Giuseppina Barra
- A.O.R.N. Santobono-Pausilipon - Ospedale Santobono, Pediatric Nephrology, Napoli, Italy
| | | | - Carmine Pecoraro
- A.O.R.N. Santobono-Pausilipon - Ospedale Santobono, Pediatric Nephrology, Napoli, Italy
| | - Gabriele Malgieri
- A.O.R.N. Santobono-Pausilipon - Ospedale Santobono, Pediatric Nephrology, Napoli, Italy
| | - Serena Ascione
- A.O.R.N. Santobono-Pausilipon - Ospedale Santobono, Pediatric Nephrology, Napoli, Italy
| | - Pasquale Barra
- A.O.R.N. Santobono-Pausilipon - Ospedale Santobono, Pediatric Nephrology, Napoli, Italy
| | - Annamaria Pagano
- A.O.R.N. Santobono-Pausilipon - Ospedale Santobono, Pediatric Nephrology, Napoli, Italy
| | - Lorenza Lepore
- A.O.R.N. Santobono-Pausilipon - Ospedale Santobono, Pediatric Nephrology, Napoli, Italy
| |
Collapse
|
9
|
Annicchiarico Petruzzelli L, Ascione S, Bruno V, Ferretti A, De Luca A, Malgieri G, Scavia G, Bresin E, Noris M, Pecoraro C. FP818Typical hemolytic uremic syndrome cohort screened for genetic complement abnormalities. Nephrol Dial Transplant 2019. [DOI: 10.1093/ndt/gfz106.fp818] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
| | - Serena Ascione
- Nephrology and Dialysis Unit, Santobono Children Hospital, Naples, Metropolitan City of Naples, Italy, Italy
| | - Valentina Bruno
- Nephrology and Dialysis Unit, Santobono Children Hospital, Naples, Metropolitan City of Naples, Italy, Italy
| | - Alfonso Ferretti
- Nephrology and Dialysis Unit, Santobono Children Hospital, Naples, Metropolitan City of Naples, Italy, Italy
| | - Angela De Luca
- Nephrology and Dialysis Unit, Santobono Children Hospital, Naples, Metropolitan City of Naples, Italy, Italy
| | - Gabriele Malgieri
- Nephrology and Dialysis Unit, Santobono Children Hospital, Naples, Metropolitan City of Naples, Italy, Italy
| | | | | | | | - Carmine Pecoraro
- Nephrology and Dialysis Unit, Santobono Children Hospital, Naples, Metropolitan City of Naples, Italy, Italy
| |
Collapse
|
10
|
Ascione S, Bruno V, Annicchiarico Petruzzelli L, Malgieri G, Nuzzi F, Pecoraro C. FP811Acute post-infectious glomerulonephritis: behind the mask. Nephrol Dial Transplant 2019. [DOI: 10.1093/ndt/gfz106.fp811] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
| | - Valentina Bruno
- Nephrology and Dialysis Unit, Santobono Children Hospital, Naples, Metropolitan City of Naples, Italy, Italy
| | | | - Gabriele Malgieri
- Nephrology and Dialysis Unit, Santobono Children Hospital, Naples, Metropolitan City of Naples, Italy, Italy
| | - Francesca Nuzzi
- Nephrology and Dialysis Unit, Santobono Children Hospital, Naples, Metropolitan City of Naples, Italy, Italy
| | - Carmine Pecoraro
- Nephrology and Dialysis Unit, Santobono Children Hospital, Naples, Metropolitan City of Naples, Italy, Italy
| |
Collapse
|
11
|
Bellia F, Lanza V, García-Viñuales S, Ahmed IMM, Pietropaolo A, Iacobucci C, Malgieri G, D'Abrosca G, Fattorusso R, Nicoletti VG, Sbardella D, Tundo GR, Coletta M, Pirone L, Pedone E, Calcagno D, Grasso G, Milardi D. Ubiquitin binds the amyloid β peptide and interferes with its clearance pathways. Chem Sci 2019; 10:2732-2742. [PMID: 30996991 PMCID: PMC6419943 DOI: 10.1039/c8sc03394c] [Citation(s) in RCA: 35] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2018] [Accepted: 01/09/2019] [Indexed: 12/22/2022] Open
Abstract
Several lines of evidence point to a compromised proteostasis associated with a reduction of the Ubiquitin Proteasome System (UPS) activity in patients affected by Alzheimer's Disease (AD) and suggest that the amyloid β peptide (Aβ) is an important player in the game. Inspired also by many reports, underlining the presence of ubiquitin (Ub) in the amyloid plaques of AD brains, here we set out to test whether Ub may bind the Aβ peptide and have any effect on its clearance pathways. By using an integrated array of MALDI-TOF/UPLC-HRMS, fluorescence, NMR, SPR, Microscale Thermophoresis (MST) and molecular dynamics studies, we consistently demonstrated that Aβ40 binds Ub with a 1 : 1 stoichiometry and K d in the high micromolar range. In particular, we show that the N-terminal domain of the Aβ peptide (through residues D1, E3 and R5) interacts with the C-terminal tail of Ub (involving residues K63 and E64), inducing the central region of Aβ (14HQKLVFFAEDVGSNK28) to adopt a mixed α-helix/β-turn structure. ELISA assays, carried out in neuroblastoma cell lysates, suggest that Aβ competitively binds Ub also in the presence of the entire pool of cytosolic Ub binding proteins. Ub-bound Aβ has a lower tendency to aggregate into amyloid-like fibrils and is more slowly degraded by the Insulin Degrading Enzyme (IDE). Finally, we observe that the water soluble fragment Aβ1-16 significantly inhibits Ub chain growth reactions. These results evidence how the non-covalent interaction between Aβ peptides and Ub may have relevant effects on the regulation of the upstream events of the UPS and pave the way to future in vivo studies addressing the role played by Aβ peptide in the malfunction of proteome maintenance occurring in AD.
Collapse
Affiliation(s)
- F Bellia
- Consiglio Nazionale delle Ricerche , Istituto di Biostrutture e Bioimmagini , Via P. Gaifami 18 , 95126 Catania , Italy .
| | - V Lanza
- Consiglio Nazionale delle Ricerche , Istituto di Biostrutture e Bioimmagini , Via P. Gaifami 18 , 95126 Catania , Italy .
| | - S García-Viñuales
- Consiglio Nazionale delle Ricerche , Istituto di Biostrutture e Bioimmagini , Via P. Gaifami 18 , 95126 Catania , Italy .
| | - I M M Ahmed
- Consiglio Nazionale delle Ricerche , Istituto di Biostrutture e Bioimmagini , Via P. Gaifami 18 , 95126 Catania , Italy .
| | - A Pietropaolo
- Dipartimento di Scienze della Salute , Università degli Studi Magna Graecia di Catanzaro , Viale Europa , 88100 , Catanzaro , Italy
| | - C Iacobucci
- Department of Pharmaceutical Chemistry & Bioanalytics , Institute of Pharmacy , Martin Luther University Halle-Wittenberg , 06120 Halle/Saale , Germany
| | - G Malgieri
- Department of Environmental , Biological and Pharmaceutical Sciences and Technologies , University of Campania "Luigi Vanvitelli" , Via Vivaldi 43 , 81100 Caserta , Italy
| | - G D'Abrosca
- Department of Environmental , Biological and Pharmaceutical Sciences and Technologies , University of Campania "Luigi Vanvitelli" , Via Vivaldi 43 , 81100 Caserta , Italy
| | - R Fattorusso
- Department of Environmental , Biological and Pharmaceutical Sciences and Technologies , University of Campania "Luigi Vanvitelli" , Via Vivaldi 43 , 81100 Caserta , Italy
| | - V G Nicoletti
- Dipartimento di Scienze Biomediche e Biotecnologiche (BIOMETEC) , sez. Biochimica medica , Università di Catania , Via Santa Sofia 97 , 95124 Catania , Italy
| | - D Sbardella
- Dipartimento di Scienze Cliniche e Medicina Traslazionale , Università di Roma Tor Vergata , Via Montpellier 1 , 00133 , Roma , Italy
| | - G R Tundo
- Dipartimento di Scienze Cliniche e Medicina Traslazionale , Università di Roma Tor Vergata , Via Montpellier 1 , 00133 , Roma , Italy
| | - M Coletta
- Dipartimento di Scienze Cliniche e Medicina Traslazionale , Università di Roma Tor Vergata , Via Montpellier 1 , 00133 , Roma , Italy
| | - L Pirone
- Consiglio Nazionale delle Ricerche , Istituto di Biostrutture e Bioimmagini , Via Mezzocannone, 16 , Naples I-80134 , Italy
| | - E Pedone
- Consiglio Nazionale delle Ricerche , Istituto di Biostrutture e Bioimmagini , Via Mezzocannone, 16 , Naples I-80134 , Italy
| | - D Calcagno
- Dipartimento di Scienze Chimiche , Università di Catania , V.le Andrea Doria 6 , 95125 Catania , Italy .
| | - G Grasso
- Dipartimento di Scienze Chimiche , Università di Catania , V.le Andrea Doria 6 , 95125 Catania , Italy .
| | - D Milardi
- Consiglio Nazionale delle Ricerche , Istituto di Biostrutture e Bioimmagini , Via P. Gaifami 18 , 95126 Catania , Italy .
| |
Collapse
|
12
|
Spaziano G, Sorrentino R, Matteis M, Malgieri G, Sgambato M, Russo TP, Terlizzi M, Roviezzo F, Rossi F, Pinto A, Fattorusso R, D'Agostino B. Nociceptin reduces the inflammatory immune microenvironment in a conventional murine model of airway hyperresponsiveness. Clin Exp Allergy 2017; 47:208-216. [PMID: 27562660 DOI: 10.1111/cea.12808] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2016] [Revised: 07/25/2016] [Accepted: 08/19/2016] [Indexed: 12/17/2022]
Abstract
BACKGROUND Nociceptin/orphanin FQ (N/OFQ) and its receptor (NOP) are involved in airway hyperresponsiveness (AHR) and inflammation. However, the role of nociceptin at modulating the inflammatory immune microenvironment in asthma is still unclear. OBJECTIVE To understand the role of N/OFQ in the regulation of a Th2-like environment, we used a conventional murine model of AHR. METHODS Balb/c and CD1 mice were sensitized to ovalbumin (OVA) and treated with saline solution or N/OFQ, at days 0 and 7. A group of Balb/c mice were killed at 7 and 14 days from the first sensitization for the inflammatory profile evaluation while a group of Balb/c and CD1 mice were aerosol-challenged from day 21 to 23 with OVA and killed 24 h later for functional evaluations. RESULTS In OVA-sensitized mice, N/OFQ significantly reduced IL-4+ CD4+ T cells in lymph nodes (LN) and IL-13 in the lungs, while it induced IFN-γ increase in the lung. The efflux of dendritic cells (DCs) to the mediastinic LN and into the lung of OVA-sensitized mice was reduced in N/OFQ-treated and sensitized mice. N/OFQ reduced the expression of CD80 on DCs, indicating its ability to modulate the activation of DCs. In a less prone Th2-like environment mice strain, such as CD1 mice, N/OFQ did not modify lung resistances as observed in BALB/c mice. Finally, spectroscopic data showed the N/OFQ was able to interact onto the membrane of DCs obtained from Balb/c rather than CD1 mice, indicating its ability to modulate AHR in a Th2-like environment with a direct activity on DCs. CONCLUSIONS AND CLINICAL RELEVANCE Our data confirmed the capability of N/OFQ to modulate the immune microenvironment in the lung of Th2-biased, OVA-sensitized Balb/c mice, suggesting N/OFQ-NOP axis as a novel pharmacological tool to modulate the inflammatory immune microenvironment in asthma.
Collapse
Affiliation(s)
- G Spaziano
- Department of Experimental Medicine, Section of Pharmacology, Second University of Naples, Naples, Italy
| | - R Sorrentino
- Department of Pharmacy (DIFARMA), University of Salerno, Fisciano, Italy
| | - M Matteis
- Department of Experimental Medicine, Section of Pharmacology, Second University of Naples, Naples, Italy
| | - G Malgieri
- Department of Environmental, Biological and Pharmaceutical Science and Technology, Second University of Naples, Caserta, Italy
| | - M Sgambato
- Department of Experimental Medicine, Section of Pharmacology, Second University of Naples, Naples, Italy
| | - T P Russo
- Department of Experimental Medicine, Section of Pharmacology, Second University of Naples, Naples, Italy
| | - M Terlizzi
- Department of Pharmacy (DIFARMA), University of Salerno, Fisciano, Italy
| | - F Roviezzo
- Department of Experimental Pharmacology, University Federico II of Naples, Naples, Italy
| | - F Rossi
- Department of Experimental Medicine, Section of Pharmacology, Second University of Naples, Naples, Italy
| | - A Pinto
- Department of Pharmacy (DIFARMA), University of Salerno, Fisciano, Italy
| | - R Fattorusso
- Department of Environmental, Biological and Pharmaceutical Science and Technology, Second University of Naples, Caserta, Italy
| | - B D'Agostino
- Department of Experimental Medicine, Section of Pharmacology, Second University of Naples, Naples, Italy
| |
Collapse
|
13
|
Grasso G, Lanza V, Malgieri G, Fattorusso R, Pietropaolo A, Rizzarelli E, Milardi D. The insulin degrading enzyme activates ubiquitin and promotes the formation of K48 and K63 diubiquitin. Chem Commun (Camb) 2015; 51:15724-7. [PMID: 26364617 DOI: 10.1039/c5cc06786c] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
We report an ATP-dependent ubiquitin conjugation with IDE which, in turn, promotes Ub-Ub linkages in tube tests. We propose a novel function for IDE as a non-canonical ubiquitin activating enzyme.
Collapse
Affiliation(s)
- G Grasso
- Dipartimento di Scienze Chimiche, Università degli Studi di Catania, V.le A. Doria 6, 95125 Catania, Italy
| | | | | | | | | | | | | |
Collapse
|
14
|
van Stralen K, Krischock L, Schaefer F, Verrina E, Groothoff J, Jager K, Tizard J, Harambat J, van Stralen KJ, Espinosa L, Groothoff JW, Hulton SA, Jankauskiene A, Schaefer F, Verrina E, Jager KJ, Cochat P, Ruggiero B, Gianviti A, Benetti E, Peruzzi L, Barbano GC, Corona F, Ventura G, Pecoraro C, Murer L, Ghiggeri GM, Pennesi M, Edefonti A, Coppo R, Emma F, Bonthuis M, van Stralen KJ, Verrina E, Edefonti A, Jager KJ, Schaefer F, Musumeci A, Graziano U, Nuzzi F, Ferraiuolo S, Severino G, Malgieri G, Minale B, Pecoraro C. Pediatric nephrology. Clin Kidney J 2011. [DOI: 10.1093/ndtplus/4.s2.6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
15
|
Malgieri G, Battista R, Ciaburri M, Santoro C. 2.6 Proposal of a New Index and Criteria for Evaluation in Ambulatory Blood Pressure Monitoring. High Blood Press Cardiovasc Prev 2008. [DOI: 10.1007/bf03263599] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
16
|
Battista R, Ciaburri M, Santoro C, Malgieri G. A Novel Index for 24-Hour Ambulatory Blood Pressure Monitoring Evaluation. High Blood Press Cardiovasc Prev 2007. [DOI: 10.2165/00151642-200714030-00015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022] Open
|